Variant report

Variant	nsv598179
Chromosome Location	chr5:54156269-54192823
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr5:54163171-54163635	K562	blood:	n/a	n/a
2	ARID3A	chr5:54163180-54163404	HepG2	liver:	n/a	n/a
3	ATF1	chr5:54188412-54188612	K562	blood:	n/a	n/a
4	ATF2	chr5:54164266-54164685	GM12878	blood:	n/a	n/a
5	ATF2	chr5:54164326-54164643	GM12878	blood:	n/a	n/a
6	ATF3	chr5:54179214-54179669	H1-hESC	embryonic stem cell:	n/a	chr5:54179411-54179431 chr5:54179447-54179456
7	ATF3	chr5:54179296-54179548	K562	blood:	n/a	chr5:54179411-54179431 chr5:54179447-54179456
8	ATF3	chr5:54179196-54179602	H1-hESC	embryonic stem cell:	n/a	chr5:54179411-54179431 chr5:54179447-54179456
9	BATF	chr5:54164293-54164657	GM12878	blood:	n/a	n/a
10	BATF	chr5:54164217-54164685	GM12878	blood:	n/a	n/a
11	BCL11A	chr5:54164196-54164719	GM12878	blood:	n/a	n/a
12	BCL11A	chr5:54164314-54164520	GM12878	blood:	n/a	n/a
13	BHLHE40	chr5:54179239-54179609	K562	blood:	n/a	chr5:54179421-54179430 chr5:54179422-54179431 chr5:54179422-54179431 chr5:54179420-54179433
14	BHLHE40	chr5:54158004-54158136	K562	blood:	n/a	n/a
15	BRCA1	chr5:54170238-54170757	Hela-S3	cervix:	n/a	n/a
16	BRCA1	chr5:54185729-54186121	Hela-S3	cervix:	n/a	chr5:54186019-54186026
17	BRCA1	chr5:54180821-54180901	Hela-S3	cervix:	n/a	n/a
18	CCNT2	chr5:54179438-54179543	K562	blood:	n/a	chr5:54179447-54179456
19	CEBPB	chr5:54170301-54170907	MCF-7	breast:	n/a	chr5:54170638-54170649 chr5:54170639-54170650 chr5:54170638-54170651
20	CEBPB	chr5:54170458-54170815	ECC-1	luminal epithelium:	n/a	chr5:54170638-54170649 chr5:54170639-54170650 chr5:54170638-54170651
21	CEBPB	chr5:54170137-54170859	Hela-S3	cervix:	n/a	chr5:54170638-54170649 chr5:54170639-54170650 chr5:54170638-54170651
22	CEBPB	chr5:54185764-54186027	IMR90	lung:	n/a	n/a
23	CEBPB	chr5:54185654-54186089	Hela-S3	cervix:	n/a	n/a
24	CEBPB	chr5:54170484-54170830	K562	blood:	n/a	chr5:54170638-54170649 chr5:54170639-54170650 chr5:54170638-54170651
25	CEBPB	chr5:54170171-54170837	ECC-1	luminal epithelium:	n/a	chr5:54170638-54170649 chr5:54170639-54170650 chr5:54170638-54170651
26	CEBPB	chr5:54185637-54186147	ECC-1	luminal epithelium:	n/a	n/a
27	CEBPB	chr5:54156188-54156388	A549	lung:	n/a	chr5:54156247-54156260 chr5:54156249-54156260
28	CEBPB	chr5:54156191-54156512	Hela-S3	cervix:	n/a	chr5:54156247-54156260 chr5:54156249-54156260
29	CEBPB	chr5:54156184-54156531	IMR90	lung:	n/a	chr5:54156247-54156260 chr5:54156249-54156260
30	CEBPB	chr5:54170325-54170939	MCF-7	breast:	n/a	chr5:54170638-54170649 chr5:54170639-54170650 chr5:54170638-54170651
31	CEBPB	chr5:54179377-54179548	H1-hESC	embryonic stem cell:	n/a	n/a
32	CEBPB	chr5:54170459-54170822	IMR90	lung:	n/a	chr5:54170638-54170649 chr5:54170639-54170650 chr5:54170638-54170651
33	CEBPB	chr5:54170523-54170714	K562	blood:	n/a	chr5:54170638-54170649 chr5:54170639-54170650 chr5:54170638-54170651
34	CEBPB	chr5:54156224-54156424	K562	blood:	n/a	chr5:54156247-54156260 chr5:54156249-54156260
35	CEBPB	chr5:54170512-54170782	HepG2	liver:	n/a	chr5:54170638-54170649 chr5:54170639-54170650 chr5:54170638-54170651
36	CEBPB	chr5:54170541-54170776	A549	lung:	n/a	chr5:54170638-54170649 chr5:54170639-54170650 chr5:54170638-54170651
37	CEBPB	chr5:54185718-54186123	ECC-1	luminal epithelium:	n/a	n/a
38	CHD1	chr5:54179542-54179799	H1-hESC	embryonic stem cell:	n/a	n/a
39	CHD2	chr5:54179242-54179599	H1-hESC	embryonic stem cell:	n/a	chr5:54179448-54179458
40	CHD2	chr5:54185719-54186073	Hela-S3	cervix:	n/a	n/a
41	CREB1	chr5:54158951-54159281	H1-hESC	embryonic stem cell:	n/a	n/a
42	CTCF	chr5:54162920-54163070	GM12866	blood:	n/a	n/a
43	CTCF	chr5:54191700-54191850	AG10803	skin:	n/a	chr5:54191757-54191775 chr5:54191759-54191772 chr5:54191752-54191773
44	CTCF	chr5:54163620-54163770	HAc	cerebellar:	n/a	n/a
45	CTCF	chr5:54163615-54163699	NHEK	skin:	n/a	n/a
46	CTCF	chr5:54191680-54191830	AoAF	blood vessel:	n/a	chr5:54191757-54191775 chr5:54191759-54191772 chr5:54191752-54191773
47	CTCF	chr5:54163300-54163450	SK-N-SH_RA	brain:	n/a	chr5:54163368-54163384 chr5:54163367-54163385
48	CTCF	chr5:54191660-54191810	K562	blood:	n/a	chr5:54191757-54191775 chr5:54191759-54191772 chr5:54191752-54191773
49	CTCF	chr5:54191700-54191850	Hela-S3	cervix:	n/a	chr5:54191757-54191775 chr5:54191759-54191772 chr5:54191752-54191773
50	CTCF	chr5:54191587-54191788	A549	lung:	n/a	chr5:54191757-54191775 chr5:54191759-54191772 chr5:54191752-54191773

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:54179305-54179355	LNCaP	prostate:	n/a
2	chr5:54180170-54180220	AG10803	skin:	n/a
3	chr5:54162153-54162203	HUVEC	blood vessel:	n/a
4	chr5:54179305-54179355	LNCaP	prostate:	n/a
5	chr5:54180170-54180220	AG10803	skin:	n/a
6	chr5:54162153-54162203	HUVEC	blood vessel:	n/a
7	chr5:54179305-54179355	HMEC	breast:	n/a
8	chr5:54180170-54180220	GM12878	blood:	n/a
9	chr5:54183619-54183669	HCF	heart:	n/a
10	chr5:54173814-54173864	AG04450	lung:	fetal
11	chr5:54179537-54179587	AG09319	gingival:	n/a
12	chr5:54173814-54173864	K562	blood:	n/a
13	chr5:54180079-54180129	AG09319	gingival:	n/a
14	chr5:54179570-54179620	AG09319	gingival:	n/a
15	chr5:54173814-54173864	GM06990	blood:	n/a
16	chr5:54177306-54177356	HEK293	kidney:	embryo
17	chr5:54179570-54179620	RPTEC	kidney:	n/a
18	chr5:54179537-54179587	RPTEC	kidney:	n/a
19	chr5:54185940-54185990	AoSMC	blood vessel:	n/a
20	chr5:54183619-54183669	ProgFib	skin:	n/a
21	chr5:54162153-54162203	CMK	blood:	n/a
22	chr5:54157713-54157763	HEK293	kidney:	embryo
23	chr5:54179537-54179587	NHDF-neo	bronchial:	n/a
24	chr5:54179570-54179620	GM12892	blood:	n/a
25	chr5:54185940-54185990	HRPEpiC	eye:	n/a
26	chr5:54179671-54179721	BJ	skin:	n/a
27	chr5:54179305-54179355	GM12878	blood:	n/a
28	chr5:54180079-54180129	AG10803	skin:	n/a
29	chr5:54179570-54179620	AG04450	lung:	fetal
30	chr5:54183619-54183669	HRPEpiC	eye:	n/a
31	chr5:54179671-54179721	PrEC	prostate:	n/a
32	chr5:54157713-54157763	GM12891	blood:	n/a
33	chr5:54173814-54173864	MCF10A-Er-Src	breast:	n/a
34	chr5:54185940-54185990	HCPEpiC	choroid plexus:	n/a
35	chr5:54179537-54179587	HRE	kidney:	n/a
36	chr5:54157713-54157763	HAEpiC	amniotic membrane:	n/a
37	chr5:54185940-54185990	LNCaP	prostate:	n/a
38	chr5:54180079-54180129	NT2-D1	testis:	n/a
39	chr5:54179671-54179721	HRPEpiC	eye:	n/a
40	chr5:54180079-54180129	HRE	kidney:	n/a
41	chr5:54179671-54179721	AG04450	lung:	fetal
42	chr5:54179671-54179721	SK-N-MC	brain:	n/a
43	chr5:54179305-54179355	HCPEpiC	choroid plexus:	n/a
44	chr5:54180254-54180304	SK-N-SH_RA	brain:	n/a
45	chr5:54179570-54179620	Hepatocyte	liver:	n/a
46	chr5:54183619-54183669	HCM	heart:	n/a
47	chr5:54180254-54180304	SAEC	small airway:	n/a
48	chr5:54173814-54173864	PANC-1	pancreas:	n/a
49	chr5:54173814-54173864	Hela-S3	cervix:	n/a
50	chr5:54179305-54179355	HRE	kidney:	n/a

No.	Distal block	Cell Line	Cell type
1	chr5:54158673..54160817-chr5:54181128..54182793,2	K562	blood:
2	chr5:53809805..53810607-chr5:54163206..54163801,2	MCF-7	breast:
3	chr5:53812926..53813845-chr5:54163058..54163822,2	MCF-7	breast:
4	chr5:53812573..53815042-chr5:54160550..54163084,2	K562	blood:
5	chr11:130183938..130184879-chr5:54175807..54176307,3	Hela-S3	cervix:
6	chr5:53813533..53814116-chr5:54191276..54191789,2	MCF-7	breast:
7	chr5:54158673..54160817-chr5:54181128..54182793,2	K562	blood:
8	chr5:54166309..54167932-chr5:54178530..54180323,2	K562	blood:
9	chr5:54166309..54167932-chr5:54178530..54180323,2	K562	blood:
10	chr5:54173158..54177091-chr5:54177548..54180449,4	K562	blood:
11	chr5:53812465..53813906-chr5:54162875..54163886,10	K562	blood:
12	chr5:54146367..54148886-chr5:54162857..54164996,2	K562	blood:
13	chr5:54187867..54189823-chr5:54194606..54196812,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-GZMK-3	chr5:54162398-54162859	NONHSAT101456
2	lnc-RP11-45H22.3.1-2	chr5:54162396-54162890	NONHSAT101458

Variant related genes	Relation type
ENSG00000232517	TF binding region
ENSG00000249843	TF binding region
ENSG00000232517	CpG island
ENSG00000249843	CpG island
ENSG00000221073	chromatin interactions
ENSG00000249843	chromatin interactions
ENSG00000196323	chromatin interactions
ENSG00000178996	chromatin interactions

Extended variants
information (count: 1286 )
Associated
traits (count: 88 )

Variant overlapped rSNPs/rCNVs (count:1286 , 50 per page) page: 1 2 3 4 5 6 7 ... 26

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs55706831	chr5:54156269-54156270	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs111616650	chr5:54156309-54156310	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs549615181	chr5:54156310-54156311	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs11436066	chr5:54156316-54156317	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs546266505	chr5:54156322-54156323	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs141769031	chr5:54156333-54156334	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs150173119	chr5:54156339-54156340	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs113701572	chr5:54156340-54156341	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs79588746	chr5:54156358-54156359	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs73128621	chr5:54156366-54156367	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs566801125	chr5:54156373-54156374	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs527902566	chr5:54156386-54156387	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs188965167	chr5:54156446-54156447	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs138505182	chr5:54156461-54156462	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs577812686	chr5:54156477-54156478	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs78471598	chr5:54156515-54156516	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs557874990	chr5:54156522-54156523	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs534238447	chr5:54156549-54156550	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs141542771	chr5:54156587-54156588	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs573950009	chr5:54156600-54156601	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs78290349	chr5:54156618-54156619	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs565221386	chr5:54156624-54156625	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs556677384	chr5:54156650-54156651	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs575536611	chr5:54156668-54156669	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs546015652	chr5:54156676-54156677	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs563235681	chr5:54156723-54156724	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs4301189	chr5:54156775-54156776	Flanking Active TSS Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs573067351	chr5:54156802-54156803	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs192694002	chr5:54156844-54156845	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs71600857	chr5:54156854-54156855	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs567736231	chr5:54156855-54156856	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs184145442	chr5:54156942-54156943	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs369776808	chr5:54156984-54156985	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs56863901	chr5:54157061-54157062	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs561609088	chr5:54157105-54157106	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs146211142	chr5:54157106-54157107	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs188294477	chr5:54157112-54157113	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs533395508	chr5:54157152-54157153	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs561171076	chr5:54157172-54157173	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs11742711	chr5:54157177-54157178	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs372841703	chr5:54157237-54157238	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs377066457	chr5:54157274-54157275	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs566676952	chr5:54157313-54157314	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs546786427	chr5:54157314-54157315	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs28585462	chr5:54157345-54157346	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs549617655	chr5:54157393-54157394	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs567586096	chr5:54157411-54157412	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs532427034	chr5:54157481-54157482	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs115905250	chr5:54157486-54157487	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs139252697	chr5:54157496-54157497	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:88)

Disease	PMID	Source
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Colorectal cancer	21645411	CNVD
Gastric cancer	22152101	CNVD
Oesophago-gastric ulcer	22152101	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Multiple myeloma	17550852	CNVD
Thoracic aortic aneurysm	21092924	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Cancer	16751803	CNVD
Autism	22495311	CNVD
Intellectual disability	22102821	CNVD
Prostate cancer	21965145	CNVD
Cancer	21183584	CNVD
Ovarian cancer	20844748	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Non-small cell lung cancer	21829676	CNVD
Breast cancer	22032731	CNVD
Esophageal cancer	20955586	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Breast cancer	17393978	CNVD
Cancer	21359685	CNVD
adenomatous polyposis	22470819	CNVD
Acute myeloid leukemia	20729466	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Hepatocellular carcinoma	16750200	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21364760	CNVD
Oral cancer	21386901	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Bladder cancer	21909424	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Lung cancer	21911935	CNVD
Breast cancer	17133270	CNVD
Breast cancer	19602461	CNVD
Renal cell carcinoma	18194544	CNVD
abnormal development	18461090	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:678 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:54155000-54156800	Enhancers	Monocytes-CD14+_RO01746	blood
2	chr5:54155200-54156600	Enhancers	Primary monocytes fromperipheralblood	blood
3	chr5:54155400-54156400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
4	chr5:54155800-54163000	Weak transcription	Aorta	Aorta
5	chr5:54156000-54156400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
6	chr5:54156000-54156400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
7	chr5:54156400-54156800	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
8	chr5:54156400-54156800	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
9	chr5:54156400-54157200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
10	chr5:54156400-54157200	Enhancers	Osteobl	bone
11	chr5:54156400-54157400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
12	chr5:54156400-54158200	Enhancers	Muscle Satellite Cultured Cells	--
13	chr5:54156400-54158200	Enhancers	NHDF-Ad	bronchial
14	chr5:54156400-54158400	Enhancers	Breast Myoepithelial Primary Cells	Breast
15	chr5:54156600-54158200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
16	chr5:54156600-54158400	Enhancers	HSMMtube	muscle
17	chr5:54156600-54158600	Enhancers	HSMM	muscle
18	chr5:54156600-54158800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
19	chr5:54156600-54159200	Enhancers	NHLF	lung
20	chr5:54156800-54158200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
21	chr5:54156800-54158200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
22	chr5:54156800-54158400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
23	chr5:54157000-54157200	Enhancers	NH-A	brain
24	chr5:54157200-54157400	Enhancers	Primary T killer memory cells from peripheral blood	blood
25	chr5:54157200-54157600	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
26	chr5:54157200-54158000	Flanking Active TSS	NH-A	brain
27	chr5:54157200-54158000	Flanking Active TSS	Osteobl	bone
28	chr5:54157200-54158200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
29	chr5:54157400-54157600	Enhancers	Colonic Mucosa	Colon
30	chr5:54157400-54158200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
31	chr5:54157400-54158200	Enhancers	Ovary	ovary
32	chr5:54157600-54158400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
33	chr5:54158000-54158200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
34	chr5:54158000-54158400	Enhancers	HMEC	breast
35	chr5:54158000-54158400	Enhancers	K562	blood
36	chr5:54158000-54158600	Enhancers	Osteobl	bone
37	chr5:54158000-54158800	Enhancers	NH-A	brain
38	chr5:54158200-54158800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
39	chr5:54158200-54163000	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
40	chr5:54158200-54163000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
41	chr5:54158200-54163000	Weak transcription	Ovary	ovary
42	chr5:54158200-54166600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
43	chr5:54158400-54163000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
44	chr5:54158400-54163000	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
45	chr5:54158400-54163000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
46	chr5:54158800-54163000	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
47	chr5:54159200-54162200	Weak transcription	NHLF	lung
48	chr5:54161200-54163000	Weak transcription	HUVEC	blood vessel
49	chr5:54162800-54163000	Enhancers	Primary T helper cells PMA-I stimulated	--
50	chr5:54162800-54163000	Enhancers	Duodenum Mucosa	Duodenum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links